Our average day begins at 10AM, although we often start earlier if necessary. Our operating hours are determined by the condition of the cells. Occasionally, we leave early to recuperate and return later in the evening.
On delivery days, we must start early. We go through all the flasks and harvest them one by one. Consequently, we might start at 4 a.m. or 6 a.m. There have been several occasions when we had to stay overnight in the laboratory, but this does not bother us at all.
Our priority is the cells because we know how crucial they are for our clients. We understand that our clients will benefit from them.
The cells are collectively transferred into a saline bottle and prepared for infusion. Overall, we complete 154 steps, process 122 flasks, and invest 44 days and 1056 man-hours for a single order. We approach each client’s order with a sense of urgency, yet we take our time to ensure precision.
This process can result in a waiting list that may extend up to six months. Our clients appreciate the importance of allowing us the necessary time, and we reciprocate by dedicating our time and effort to each of them. Perhaps, unknowingly, this determination and high expectations have transformed us from scientists into artisans.
One thing is certain: we are proud to say that we know what we are doing and are good at what we do.
Wharton’s Jelly, found within the umbilical cord, is a preferred source of Mesenchymal Stem Cells (MSCs) due to its abundance, ethical sourcing, and versatility. These stem cells are collected immediately after birth from the umbilical cord, a process that is both simple and non-invasive. Once harvested, the MSCs undergo careful processing to ensure they are of the highest quality and safe for medical use.
Wharton’s Jelly-derived MSCs stand out because they offer a rich and concentrated source of stem cells, significantly more abundant than other sources. Moreover, their collection is ethically sound, as it involves no harm to embryos or fetuses, unlike embryonic stem cell sourcing. The tissue from which these cells are derived is also less likely to carry diseases or infections, adding to their safety and reliability.
Due to these advantages, MSCs from Wharton’s Jelly are increasingly used in a range of medical applications, from regenerating damaged tissues and treating autoimmune disorders to exploring their potential in cosmetic treatments for skin rejuvenation. Their versatility and high quality make them an ideal choice in modern regenerative medicine and beyond.
Adipose tissue, commonly known as body fat, is a valuable source of Mesenchymal Stem Cells (MSCs), particularly for autologous applications—treatments where the donor and recipient are the same person. These stem cells are collected from the fatty tissue that is often removed during procedures like liposuction, which is commonly done for cosmetic reasons.
After the fat is removed, it undergoes a process to isolate the MSCs, which are then prepared for medical use. The benefit of using adipose-derived MSCs in autologous treatments is that the cells come from the patient's own body, reducing the risk of rejection or complications that can arise when cells from another person are used.
Adipose-derived MSCs are favoured because they are easy to collect and are found in high concentrations within fat tissue. This makes them an excellent choice for personalised medical treatments aimed at repairing damaged tissues, addressing injuries, or managing conditions like autoimmune diseases.
In summary, adipose-derived MSCs provide a practical and abundant source of stem cells for autologous use. Their collection is straightforward and minimally invasive, and because they are derived from the patient’s own body, they offer a safer and more personalised approach to medical treatment.
The Mesenchymal Stem Cell (MSC) culture process is an advanced and time-consuming procedure requiring significant effort, experience, and meticulous planning by our lab team. From raw source to completion, every step is thoroughly documented. Our objective is to culture MSCs of the highest quality, ensuring their "stemness" is at its peak.
Each source of MSCs exhibits unique characteristics that must be managed differently. Our many years of accumulated research and experience enable us to accurately identify these characteristics and maximise their "stemness".
Our MSCs must meet our stringent criteria before being approved for use.
The start of our process involves running a series of tests and procedures namely; cell count, the multiplication and differentiation ability tests, isolating inactive cells, morphology tests, etc. This is to ensure the MSCs are fit to proliferate.
Every batch undergoes our Continuous Sterility Review where sterility tests are done on intervals throughout the culture process. This allows us to ensure the process is consistently sterile.
Once completed, the protocol to harvest the MSCs from the incubator is vital to ensure the cells are highly viable for application. We optimize the preparation time and customize for different treatments at different location in various delivery method. Therefore we can deliver the MSCs at its best condition.